Optometry & Visual Performance 181 Volume 14 | Issue 2 | June 2026 Student Corner • An Approach to Understanding Amblyopia Etiology and Diagnosis Tamara Petrosyan, OD • SUNY College of Optometry • New York, New York Tamara Petrosyan, OD New York, New York Associate Clinical Professor, SUNY College of Optometry and East New York Diagnostic and Treatment Center OD, SUNY College of Optometry, 2009 BA, Ithaca College, 2006 Residency, Northport Veterans Affairs Medical Center Director/Trustee, OEPF : Introduction Amblyopia, derived from the Greek words “amblys” (blunt or dull) and “ops” (eye), literally translates to “blunt eye.” This ancient term captures the essence of a condition in which vision is significantly reduced despite the absence of any obvious structural or pathological abnormality in the eye itself. Hippocrates, around 450 B.C.E., provided one of the earliest recorded descriptions in his aphorisms: “When the doctor sees nothing and the patient sees very little, the diagnosis is amblyopia.” This observation remains remarkably relevant today, highlighting the functional nature of the disorder— a diagnosis of exclusion where the clinician observes no overt ocular anomaly, yet best-corrected visual acuity (BCVA) is impaired, typically defined as less than 20/20 (or a ≥2-line interocular difference) in one or both eyes. Clinically, amblyopia is classified into functional (neurodevelopmental, reversible with appropriate intervention) and organic (resulting from identifiable structural or pathological damage to the visual pathway). Functional amblyopia arises from abnormal visual experience during early development, most commonly due to strabismus, anisometropia, high isoametropia, or form deprivation. Organic amblyopia stems from conditions such as optic neuropathy, retinal dystrophies, or neoplasms that mimic the presentation but require entirely different management. Distinguishing between these is a cornerstone of accurate diagnosis. Amblyopia ranks among the most prevalent and consequential neurodevelopmental visual disorders in clinical practice. It affects 2–5% of the global population and, according to the Pediatric Eye Disease Investigator Group (PEDIG), is the leading cause of unilateral vision loss in adults aged 20– 70+, surpassing trauma, infections, and other ocular diseases combined. In children under 20 years of age, amblyopia accounts for more vision loss than all other pediatric ocular diseases and physical trauma combined. In the United States, the Multi-Ethnic Pediatric Eye Disease Study (MEPEDS) and the Vision in Preschoolers (VIP) study report a prevalence of approximately 3–4% among preschool-aged children, with roughly 500,000 Americans living with visual impairment attributable to amblyopia. The consequences extend far beyond reduced visual acuity in the affected eye. Individuals with amblyopia typically rely on a single “good” eye, placing them at a >25% lifetime risk of vision impairment in the better-seeing eye from unrelated causes such as age-related macular degeneration, glaucoma, retinal detachment, or accidental trauma. Dependence on a single functioning eye dramatically increases vulnerability to bilateral functional blindness. Additional lifelong consequences include increased risk of accidents, falls, and off-axis injuries due to impaired depth perception, contrast sensitivity, and peripheral awareness; educational and occupational limitations stemming from persistent deficits in reading speed, visual attention, fine motor coordination, and perceptual skills; and psychosocial effects, including social stigma, reduced self-esteem, and restricted participation in activities requiring excellent binocular vision. Amblyopia imposes a disproportionate public health burden. Research demonstrates that it generates two to three times more disabilityadjusted life years (DALYs) than congenital cataracts or childhood glaucoma. Validated patient-reported outcome measures highlight the breadth of impact: the PedEyeQ (developed by PEDIG) shows that children with residual amblyopia score significantly worse than peers in functional vision, social interactions, eye-related bother, and emotional frustration domains; the ATS QOL and NEI-VFQ-25 reveal that adults experience ongoing difficulties with daily visual tasks, reduced confidence, and lower overall quality of life.
RkJQdWJsaXNoZXIy MjEyMDQ0Nw==